PPP098: Deprescribing in 2020 with Dr Lisa Kouladjian O'Donnell

Kristin flies solo this week to talk to Dr Lisa Kouladjian O'Donnell, a consultant pharmacist and postdoctoral research associate affiliated with the NHMRC Cognitive Decline Partnership Centre, The University of Sydney, and the Kolling Institute, Royal North Shore Hospital, NSW.

Kristin and Lisa discuss:

• definitions of polypharmacy and deprescribing

• drivers of polypharmacy

• at-risk populations

• a collaborative approach to deprescribing

• the Drug Burden Index (DBI) calculator

You can read more about Lisa’s work here.

The Goal-directed Medication review Electronic Decision Support System (G-MEDSS) is here.

You can also learn more about deprescribing from some of our past episodes:

• PPP009: Deprescribing with Amy Page

• PPP028: Principles of Geriatric Medicine with Rohan Elliott

• PPP029: What is Polypharmacy Exactly? With Nashwa Masnoon and Sepehr Shakib